Northern Venture Trust PLCLSE: NVT

Northern Venture Trust: Half-yearly Financial Report for the six mont...

· Issued by Northern Venture Trust PLC via GlobeNewswire

Summary by 6ix AI

Northern Venture Trust PLC, a venture capital trust (a UK listed fund that invests mainly in unquoted young companies), reported unaudited net assets of £151.7m and net asset value per share of 58.7p at 30 September 2026, with a total return of 2.1p per share for the six months ended 30 September 2026 (2025: 0.8p).

Key details

  • Interim dividend of 1.5 pence per share for the year ending 31 March 2027, to be paid on 20 January 2027 to shareholders on the register on 18 December 2026.
  • The portfolio value rose by £6.2 million over the 31 March 2026 holding value, made up of £5.1 million realised gains and £1.1 million unrealised gains. Sales included the remaining holding in The Beauty Tech Group for £8.0 million and Send Technology Solutions for initial proceeds of £3.3 million.
  • Five new investments totalling £4.7 million were made in the period, plus £2.6 million into seven existing portfolio companies. Since the period end, it invested a second tranche of £1.5 million in Givestar and £1.5 million in Bureau.
  • From 1 October 2026, the annual management fee paid to investment adviser Mercia Fund Management Limited fell from 2.06% to 2.00% of net assets, and Mercia no longer charges initial management fees to new portfolio companies.
  • Cash balances were £50.9 million at 30 September 2026 (31 March 2026: £36.5 million). On 30 September 2026, with the other Northern VCTs, it launched an offer to raise up to £10 million.

What’s still pending

  • The share offer to raise up to £10 million closes on 31 March 2027, or earlier if fully subscribed.
  • The interim dividend is scheduled to be paid on 20 January 2027.

6ix AI wrote this summary from the release below and checked it against the release.

20 November 2026

Northern Venture Trust PLC
Half-Yearly Financial Report for the six months ended 30 September 2026

Northern Venture Trust PLC is a Venture Capital Trust (VCT) advised by Mercia Fund Management Limited (the Investment Adviser). The trust was one of the first VCTs launched on the London Stock Exchange in 1995. It invests mainly in unquoted venture capital holdings and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth.

Financial summary

Unaudited six months ended
30 September
2026
Unaudited six months ended
30 September
2025
Audited year
ended
31 March
2026
Net assets£151.7m£131.7m£138.2m
Net asset value per share58.7p60.7p57.8p
Return per share
Revenue0.1p0.1p0.2p
Capital2.0p0.7p(0.8)p
Total2.1p0.8p(0.6)p
Dividend per share declared in respect of the period1.5p1.6p3.1p
Cumulative return to shareholders since launch
Net asset value per share58.7p60.7p57.8p
Dividends paid per share*199.9p196.8p198.4p
Net asset value plus dividends paid per share258.6p257.5p256.2p
Mid-market share price at end of period56.0p56.5p57.0p
Share price discount to net asset value4.5%6.9%1.4%
Tax-free dividend yield
(based on net asset value per share)**
4.9%5.2%5.0%

* Excluding interim dividend not yet paid.

** The dividend yield is calculated by dividing the dividends declared in the 12-month period ended on each reference date by the net asset value per share at the start of that period.

Half-yearly financial report

It is my pleasure to present our Half-Yearly Financial Report. UK economic conditions from April to September remained challenging: the prolonged conflict in the Middle East pushed energy prices sharply higher, inflation rose to 3.5% in September, and gilt yields reached their highest level since 2007 amid concern over the public finances. Against this backdrop, the Company had a strong period for realisations and maintained its long-term strategy of investing in promising early-stage businesses, supporting its existing portfolio companies, and generating cash from realisations.

Venture capital investment activity and portfolio update
The value of the portfolio increased by £6.2 million over the 31 March 2026 holding value, comprising unrealised gains of £1.1 million and realised gains of £5.1 million. Gains on the stronger performers more than offset reductions elsewhere. Pure Pet Food increased in value by £2.7 million (including the partial realisation), Risk Ledger by £0.6 million and Semble by £0.6 million, while the largest reductions were in Scalpel and Axis Spine Technologies.

In the reporting period we sold our remaining holding in The Beauty Tech Group for £8.0 million. Together with the £2.5 million realised at its IPO on the London Stock Exchange in October 2025, the investment has delivered a 7.4x return on our original cost. We first invested in 2018.

In July 2026 we sold Send Technology Solutions for initial proceeds of £3.3 million, a 1.7x return on cost. We sold our holding in Buoyant Upholstery for an initial £1.3 million, a lifetime return of 2.5x. We also realised part of our holding in Pure Pet Food for £1.4 million, 5.5x the cost of the shares sold, and sold our remaining AIM-quoted holdings in RTC Group, CelLBxHealth and Velocity Composites for total proceeds of £0.4 million. In aggregate, realisations in the period were £5.1 million above the total 31 March 2026 holding values.

During the period, we made five new investments totalling £4.7 million: Flok Health (£1.0 million), a digital healthcare company providing AI-enabled physiotherapy services; Fifth Dimension AI (£1.0 million), a software company providing decision-intelligence tools for the real estate and real-assets sector; PlannerPal (£1.0 million), a provider of financial adviser workflow and compliance software; Equals (£0.9 million), a music-focused social networking and engagement platform; and Givestar (£0.8 million), a digital fundraising and charitable giving platform. We also deployed £2.6 million into seven existing portfolio companies.

Since the period end we have made a second tranche investment in Givestar of £1.5 million and an investment of £1.5 million in Bureau, a provider of office booths and meeting pods.

Results and dividend
The total return per share before dividends for the six months ended 30 September 2026 was 2.1 pence (2025: 0.8 pence), equivalent to 3.6% of the audited net asset value (NAV) per share of 57.8 pence at 31 March 2026. After deducting the final dividend for the year to 31 March 2026 of 1.5 pence, paid in September 2026, and taking account of the accretive effect of share issues above NAV and buy-backs below it, the unaudited NAV per share at 30 September 2026 was 58.7 pence.

In 2018 we introduced a target dividend yield of 5% of opening NAV, and have exceeded it every year since. Consistent with that target, the Board has declared an interim dividend of 1.5 pence per share in respect of the year ending 31 March 2027, to be paid on 20 January 2027 to shareholders on the register on 18 December 2026.

We continue to operate our dividend investment scheme, which enables shareholders to invest their dividends in new ordinary shares free of dealing costs and with the benefit of the tax reliefs available on new VCT share subscriptions. In September 2026, the Company issued 890,347 new shares under the scheme in respect of the final dividend. Details of the scheme are in the dividend section of our website at www.mercia.co.uk/vcts/nvt/.

Share issues and buy-backs
Under the extended 2025/26 share offer, the Company issued 22,761,845 shares on 2 April 2026 for gross proceeds of £14.1 million.

On 30 September 2026, in conjunction with the other Northern VCTs, we launched an offer to raise up to £10 million. The offer closes on 31 March 2027, or earlier if fully subscribed, and existing shareholders of any Northern VCTs receive a 0.5% discount on offer costs. Full details are on the Company’s website at mercia.co.uk/vcts.

We have maintained our policy of buying back the Company’s shares in the market when necessary to maintain liquidity, at a 5% discount to NAV. During the period the Company purchased 4,074,145 shares for cancellation at an average price of 55.2 pence, representing 1.7% of the opening share capital.

During the period the Company cancelled its share premium account, transferring £61.3 million to the capital reserve and increasing the reserves available for distribution.

Management fee
With effect from 1 October 2026, the Board has agreed revised fee arrangements with Mercia. The annual management fee has reduced from 2.06% to 2.00% of net assets, while the fee on cash balances has been restructured to reflect the level of cash held for future investment. Mercia will also no longer charge initial management fees to new portfolio companies. The Board believes this will benefit shareholders by making the Company a more attractive investor to high-quality, early-stage businesses, improving our access to the best opportunities and ensuring more of the capital we invest goes directly into growing those businesses. Further details are set out at the end of this announcement.

VCT legislation and qualifying status
The Company has continued to meet the stringent and complex qualifying conditions laid down by HM Revenue & Customs for maintaining its approval as a VCT. The Investment Adviser monitors the position closely and reports regularly to the Board. Philip Hare & Associates LLP has continued to act as independent adviser to the Company on VCT taxation matters.

As reported in the Annual Report, with effect from 6 April 2026, the Government increased the annual and lifetime investment limits for VCT-qualifying companies and cut income tax relief on new VCT subscriptions from 30% to 20%. The impact on investor appetite for VCTs remains uncertain.

Cash and liquidity
Cash balances at 30 September 2026 were £50.9 million (31 March 2026: £36.5 million), higher than usual following the April allotment and the realisations in the period. The Directors consider it important that the Company holds adequate cash to support the existing portfolio and to seize attractive investment opportunities. The Board will be mindful of the fundraising environment for VCTs as the implications of the new tax regime become apparent, but expects in the medium term to carry a significantly lower proportion of its resources as cash once it has better insight into the consequences of the tax changes for the VCT sector as a whole.

Outlook
Despite ongoing geopolitical and economic uncertainties, the realisations achieved in the period show that the portfolio can deliver value for the shareholders through the cycle. The Company will continue to invest selectively and to realise investments where the price is right. We believe the Company is well placed to continue to create shareholder value in the years ahead.

The Board thanks shareholders for their continuing support.

On behalf of the Board

Deborah Hudson
Chair

Statement of the Directors’ responsibilities

Responsibility statement
In accordance with Disclosure and Transparency Rule (DTR) 4.2.10, Deborah Hudson (Chair), Brigid Sutcliffe (Chair of the Audit & Risk Committee) and John Milad, being the Directors of the Company, confirm that to the best of their knowledge:

(a) the condensed set of financial statements, which has been prepared in accordance with Financial Reporting Standard 104 “Interim Financial Reporting”, gives a true and fair view of the assets, liabilities, financial position and profit of the Company as required by DTR 4.2.10;

(b) the Half-Yearly Financial Report includes a fair review of the information required by DTR 4.2.7, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

(c) a description of the principal risks and uncertainties facing the Company for the remaining six months of the financial year is set out under the summary of principal risks and uncertainties below, in accordance with DTR 4.2.7; and

(d) other than the change in the management fee referred to in the Chair’s statement, there were no related party transactions in the first six months of the current financial year that are required to be disclosed, in accordance with DTR 4.2.8.

Principal risks and uncertainties
In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Financial Statements for the year ended 31 March 2026 (“the Annual Report”). The Board considers that the present processes for mitigating those risks remain appropriate. Following the realisation of all the Company’s quoted investments, the Board has removed stock market risk from the principal risks.

The principal risks faced by the Company are:

  • Artificial intelligence and advanced technology risk
  • Availability of qualifying investments risk
  • Economic and geopolitical risk
  • Financial risk
  • Investment and liquidity risk
  • Legislative and regulatory risk
  • Operational risk
  • Performance of the Investment Adviser risk
  • VCT qualifying status risk

A detailed explanation of the principal risks facing the Company can be found in the Annual Report and Financial Statements for the year ended 31 March 2026 on pages 28 to 30, as well as in Note 18 on Financial Instruments on pages 78 to 80 of that report. Copies can be viewed or downloaded from the Company’s website: www.mercia.co.uk/vcts.

Environmental, Social and Governance considerations
The Company is committed to conducting its affairs responsibly and considers environmental, social and governance (ESG) issues as part of its operations. More details of the Company’s considerations can be found in the Responsible Investment section in the Annual Report and Financial Statements for the year ended 31 March 2026 on pages 31 to 33.

Going concern
The Board has assessed the Company’s operation as a going concern. The Company’s business activities, together with the factors likely to affect its future development, performance and position are set out earlier in the Half-Yearly Financial Report. The Directors have satisfied themselves that the Company’s cash position is adequate to enable the Company to continue as a going concern under downside scenarios. The portfolio remains well funded and the Investment Adviser’s investment team are ensuring that management teams undertake adequate cost control and cash flow planning. The major cash outflows of the Company (namely investments, share buy-backs and dividends) are within the Company’s control. The Board’s assessment of liquidity risk and details of the Company’s policies for managing its capital and financial risks are shown in Note 18 of the Annual Report and Financial Statements for the year ended 31 March 2026 on pages 78 to 80. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the Half-Yearly Financial Report.

Cautionary statement
This report may contain forward-looking statements with regard to the financial condition and results of the Company, which are made in the light of current economic and business circumstances. Nothing in this report should be construed as a profit forecast.

For and on behalf of the Board:

Deborah Hudson
Chair
20 November 2026

Investment portfolio
As at 30 September 2026 (unaudited)

DescriptionCost
£000
Valuation
£000
% of net assets
by value
Fifteen largest venture capital investments
Pure Pet FoodProduction of organic pet food1,4168,8275.8
Risk LedgerCyber security focused on supply chain risk2,7874,7663.1
SemblePractice management software for healthcare clinics2,9614,5263.0
PimberlyProduct information management software2,0603,4792.3
Broker InsightsPlatform connecting insurers and brokers3,2313,2312.1
Biological Preparations GroupEnvironmental biotechnology products2,3663,1922.1
Tutora (t/a Tutorful)Platform for parents/students to engage tutors3,3052,9411.9
RockarE-commerce and fulfilment platform for new car sales1,8772,7261.8
Forensic AnalyticsCall data communications analytics software2,7172,7171.8
VoxPopMeVideo-based consumer analysis platform1,9472,6881.8
Ridge PharmaSale of pharmaceuticals (branded, generics, specials)1,4972,5891.7
Turbine Simulated Cell TechnologiesSimulation of cell reaction to disease treatment2,3722,5381.7
AdministrateSaaS training management and LMS platform3,4442,5081.7
LMC SoftwareSocial care management software for care homes1,9502,2961.5
Thanks BenEmployee benefits orchestration platform2,2802,2801.5
Fifteen largest venture capital investments36,21051,30433.8
Other venture capital investments57,24248,56532.0
Total venture capital investments93,45299,86965.8
Net current assets51,80334.2
Net assets151,672100.0

Extracts from the unaudited half-yearly financial statements for the six months ended 30 September 2026 are set out below

Condensed income statement

For the six months ended 30 September 2026

Unaudited six months endedUnaudited six months endedAudited year ended
30 September 202630 September 202531 March 2026
RevenueCapitalTotalRevenueCapitalTotalRevenueCapitalTotal
£000£000£000£000£000£000£000£000£000
Gain/(loss) on disposal of investments–5,0855,085–(2)(2)–(197)(197)
Movements in fair value of investments–1,0861,086–2,4132,413–8787
–6,1716,171–2,4112,411–(110)(110)
Dividend and interest income1,025–1,025933–9331,803–1,803
Investment management fee(334)(1,001)(1,335)(305)(915)(1,220)(629)(1,888)(2,517)
Other expenses(257)–(257)(289)–(289)(563)–(563)
Return before tax4345,1705,6043391,4961,835611(1,998)(1,387)
Tax on return(104)104–(50)50–(118)118–
Return after tax3305,2745,6042891,5461,835493(1,880)(1,387)
Return per share0.1p2.0p2.1p0.1p0.7p0.8p0.2p(0.8)p(0.6)p

Condensed balance sheet

As at 30 September 2026

Unaudited 30 September
2026
Unaudited 30 September
2025
Audited 31 March
2026
£000£000£000
Fixed assets
Investments99,869100,825101,676
Current assets
Debtors1,029118197
Cash and cash equivalents50,92430,94936,499
51,95331,06736,696
Creditors (amounts falling due within one year)(150)(188)(208)
Net current assets51,80330,87936,488
Net assets151,672131,704138,164
Capital and reserves
Called-up equity share capital64,63954,23259,745
Share premium31144,07353,443
Capital redemption reserve11,8709,80610,851
Revaluation reserve6,4189,24411,279
Capital reserve67,67113,6011,894
Revenue reserve763748952
Total equity shareholders' funds151,672131,704138,164
Net asset value per share58.7p60.7p57.8p

Condensed statement of changes in equity

Called-up share capitalShare premiumCapital redemption reserveRevaluation reserveCapital reserveRevenue reserveTotal
£000£000£000£000£000£000£000
Six months ended 30 September 2026 (unaudited)
At 1 April 202659,74553,44310,85111,2791,894952138,164
Return after tax–––(4,861)10,1353305,604
Dividends paid––––(3,371)(519)(3,890)
Net proceeds of share issues5,9138,178––––14,091
Shares purchased for cancellation(1,019)–1,019–(2,261)–(2,261)
Cancellation of share premium account–(61,310)––61,310––
Costs of share premium cancellation––––(36)–(36)
At 30 September 202664,63931111,8706,41867,671763151,672
Six months ended 30 September 2025 (unaudited)
At 1 April 202549,30235,3488,4766,77920,451895121,251
Return after tax–––2,465(919)2891,835
Dividends paid––––(2,835)(436)(3,271)
Net proceeds of share issues6,2608,725––––14,985
Shares purchased for cancellation(1,330)–1,330–(3,096)–(3,096)
At 30 September 202554,23244,0739,8069,24413,601748131,704
Year ended 31 March 2026
At 1 April 202549,30235,3488,4766,77920,451895121,251
Return after tax–––4,500(6,380)493(1,387)
Dividends paid––––(6,679)(436)(7,115)
Net proceeds of share issues12,81818,095––––30,913
Shares purchased for cancellation(2,375)–2,375–(5,498)–(5,498)
At 31 March 202659,74553,44310,85111,2791,894952138,164

Condensed statement of cash flows

For the six months ended 30 September 2026

Unaudited six months endedUnaudited six months endedAudited year ended
30 September 202630 September 202531 March 2026
£000£000£000
Cash flows from operating activities
Return before tax5,6041,835(1,387)
Adjustments for:
(Gain)/loss on disposal of investments(5,085)2197
Movements in fair value of investments(1,086)(2,413)(87)
(Increase)/decrease in debtors(34)2,777(24)
Decrease in creditors(58)(432)(412)
Net cash (outflow)/inflow from operating activities(659)1,769(1,713)
Cash flows from investing activities
Purchase of investments(7,329)(5,393)(15,601)
Proceeds on disposal of investments14,50951610,076
Net cash inflow/(outflow) from investing activities7,180(4,877)(5,525)
Cash flows from financing activities
Issue of ordinary shares14,60915,47431,943
Share issue expenses(518)(489)(1,032)
Purchase of ordinary shares for cancellation(2,261)(3,096)(5,498)
Costs of share premium cancellation(36)––
Equity dividends paid(3,890)(3,271)(7,115)
Net cash inflow from financing activities7,9048,61818,298
Net increase in cash and cash equivalents14,4255,51011,060
Cash and cash equivalents at beginning of period36,49925,43925,439
Cash and cash equivalents at end of period50,92430,94936,499

Other matters

The Financial Statements are prepared in accordance with accounting policies consistent with Financial Reporting Standard 102 (“FRS 102”), Financial Reporting Standard 104 (“FRS 104”) – Interim Financial Reporting, with the Companies Act 2006 and the Statement of Recommended Practice, ‘Financial Statements of Investment Trust Companies and Venture Capital Trusts’ (“the SORP”) (updated in December 2025) issued by the Association of Investment Companies (“AIC”). These condensed financial statements comply with FRS 104, applying the recognition and measurement principles of FRS 102. The Financial Statements have been prepared on a going concern basis.

The preparation of the Financial Statements requires management to make judgements and estimates that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The most critical estimates and judgements relate to the determination of carrying value of investments at fair value through profit or loss (“FVTPL”) in accordance with FRS 102 sections 11 and 12. The Company values investments by following the International Private Equity and Venture Capital Valuation (“IPEV”) Guidelines as updated in 2025 and further detail on the valuation techniques used is outlined in the Annual Report and Financial Statements for the year ended 31 March 2026.

The accounting policies have been applied consistently throughout the period. Full details of principal accounting policies are disclosed in Note 1 on page 65 of the Annual Report and Financial Statements for the year ended 31 March 2026. The significant accounting estimates and judgements applied are consistent with those disclosed in the Annual Report for the year ended 31 March 2026.

Details of the agreement under which the investment management fee and performance-related fee are paid are given in the Directors’ Report on page 39 and in Note 3 on page 68 of the Annual Report and Financial Statements for the year ended 31 March 2026. The investment management fee for the six months ended 30 September 2026 has been calculated in accordance with these arrangements. As previously announced, revised fee arrangements under the investment advisory agreement became effective on 1 October 2026. Under the revised arrangements, the annual management fee has been reduced from 2.06% to 2.00% of net assets, with amendments also made to the basis of calculating management fees on cash balances (now 1.75% on balances over £30 million – previously 1.00% on balances over £20 million) and the frequency of fee calculations. In addition, no initial management fees will be charged to new portfolio companies from that date.

The interim dividend of 1.5 pence per share for the year ending 31 March 2027 will be paid on 20 January 2027 to shareholders on the register on 18 December 2026.

The calculation of the return per share is based on the return after tax for the six months ended 30 September 2026 and on 260,666,935 (30 September 2025: 219,187,995) ordinary shares, being the weighted average number of shares in issue during the period.

The calculation of net asset value per share is based on the net assets at 30 September 2026 divided by the 258,557,032 (30 September 2025: 216,925,150) ordinary shares in issue at that date.

The information set out in this announcement does not constitute the Company’s statutory accounts within the terms of section 434 of the Companies Act 2006 for the periods ended 30 September 2026 and 30 September 2025 and is unaudited. The financial information for the year ended 31 March 2026 does not constitute statutory accounts within the terms of section 434 of the Companies Act 2006 and is derived from the statutory accounts for that financial year, which have been delivered to the Registrar of Companies. The Auditor reported on those accounts; their report was unqualified and did not contain a statement under s498(2) or (3) of the Companies Act 2006.

The Half-Yearly Financial Report is being sent to shareholders and copies will be made available to the public at the registered office of the Company, the National Storage Mechanism and also electronically at www.mercia.co.uk/vcts.

Northern Venture Trust PLC on 6ix

Earlier from Northern Venture Trust

Later from Northern Venture Trust

All Northern Venture Trust news releases